Definitive Contract HHSD200201587699C
- Not listed
- This is a federal contract award to Westat, Inc., a prominent professional services firm, by the Centers for Disease Control and Prevention (CDC). The contract, valued at $117,308,763, is a Cost Plus Fixed Fee Definitive Contract with an ultimate completion date of December 31, 2012. The contract does not have a set-aside designation. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies, including the Department of...
- This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract is for "TECHNICAL ASSISTANCE FOR PATIENT-CENTERED OUTCOMES RESEARCH" and has a ceiling value of $508,439.00. The contract is a definitive, firm-fixed-price contract awarded on September 14, 2015, with a final completion date of June 13, 2017. The contract does not have a set-aside designation. Westat, Inc. is...
- This $176,570 firm fixed price contract was awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) to Westat, Inc., a for-profit professional services firm. The contract is a Blanket Purchase Agreement (BPA) Call under the master BPA "Achieving Public Health Impact Through Research (APHITR)." Westat will provide services such as survey research, data collection and analysis, program evaluation, statistical analysis, and information...
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to Westat, Inc., a for-profit professional services provider. The contract is for $246,266.00 and supports "Systematic Screening and Assessment of Community Pharmacy Strategies to Address Heart Disease and Stroke Prevention." It is not designated as a set-aside contract. The work is performed under the parent "Technical...
- This federal contract award, valued at $234,136.00, was issued by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract is a Blanket Purchase Agreement (BPA) Call under the "Achieving Public Health Impact Through Research (APHITR)" BPA, indicating that it is part of a larger contract vehicle. The purpose of the contract is to support the reporting of drought and health effects. As a...
- This is a cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a professional services firm based in Rockville, Maryland. The $11,663,230.00 contract is for BAA Topic 5.2, which involves comparing laboratory-confirmed influenza among adults aged 18-64. The contract has a period of performance through September 15, 2023. Westat has extensive experience conducting research, data collection, and program evaluation for various...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm that provides research, technical assistance, and program support services to various federal agencies. The contract, a Blanket Purchase Agreement (BPA) call with a ceiling value of $1,109,511.00, is for general support functions related to "engaging the private sector". The contract is not set aside. Westat has extensive experience...
- This is a Firm Fixed Price contract awarded to Westat, Inc. by the Centers for Disease Control and Prevention (CDC) for "HEALTH SYSTEM CHANGES TO ADDRESS RISK FACTORS IN CANCER". The contract is a call under the Achieving Public Health Impact Through Research (APHITR) Blanket Purchase Agreement (BPA), with a total ceiling value of $547,958.00 and a completion date of September 29, 2023. Westat, a for-profit professional services firm, has been providing a wide range of services to...
- This is a $7,133,828 firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc. to develop and evaluate innovative methods to estimate the secondary attack rate of respiratory virus-associated illness. The contract has no set-aside designation. Westat is a for-profit professional services firm that provides a range of research, data collection, and program evaluation services to federal agencies, including the Department of Health and Human...
- This is a time and materials contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent research and professional services firm based in Rockville, Maryland. The contract, valued at $1,446,924.00, is for communication support services for the CDC's Prevention Research and Translation Branch (PRTB). The contract is a Blanket Purchase Agreement (BPA) call and was not set aside for any specific business category. Westat has demonstrated extensive...
This federal contract award, with an ID of HHSD200201587699C, was issued by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, valued at $4,986,472.00, is for DIABETES PREVENTION-DM REGISTREIS services. This is a Cost Plus Fixed Fee type contract with a definitive completion date of March 31, 2021. The contract does not have a set-aside designation. Westat, Inc. is an experienced government contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with various federal agencies, including the National Cancer Institute, the CDC, and the National Institute of Child Health and Human Development. Through these IDVs and other contract awards, Westat provides a wide range of research, technical assistance, and program support services to the government, particularly in the areas of public health, education, and social policy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 5/18/20 | |
| 1 | Change Order | $0 | 5/11/16 | |
| Not listed | Not listed | $5.0m | 9/8/15 |